Pulmonary Nocardia otitidiscaviarum infection in a patient with chronic respiratory infection

Internal Medicine

Volumn 37, Issue 10, 1998, Pages 872-876

  Taniguchi, Haruko ^a   Mukae, Hiroshi ^a   Ashitani, Jun Ichi ^a   Ihi, Toshihiko ^a   Sakamoto, Akira ^a   Kohno, Shigeru ^b   Matsukura, Shigeru ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Acute on chronic respiratory infection; Drug susceptibility; Pulmonary nocardiosis

Indexed keywords

CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; MINOCYCLINE;

AGED; ARTICLE; BACTERIUM CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG INFECTION; MALE; NOCARDIA; NOCARDIA OTITIDISCAVIARUM; NOCARDIOSIS; ORAL DRUG ADMINISTRATION; RESPIRATORY TRACT INFECTION; THORAX RADIOGRAPHY;

EID: 0031740651     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.872     Document Type: Article

References (14)

1. Beaman BL, Saubolle MA, Wallace RJ. Nocardia, Rhodococcus, Streptomyces, Oerskovia, and other aerobic actinomycetes of medical importance, in: Manual of Clinical Microbiology, Murray PR, Baron EJ, Pfaller MA, et al., Eds. American Society for Microbiology, Washington DC, 1995, p. 379-399.
2. Beaman BL, Burnside J, Edwards B, Causey W. Nocardial infections in the United States, 1972-1974. J Infect Dis 134: 286-289, 1976.
3. Lechevalier HA. Nocardioform actinomycetes. in: Bergey's Manual of Systemic Bacteriology. Williams ST, Sharpe ME, Holt JG, Eds. The Williams & Wilkins Co, Baltimore, 1989. pp. 2348-2404.
4. Mikami Y, Yazawa K. Susceptibility patterns of pathogenic Nocardia to some selected antimicrobial agents and their usefulness in the identifica tion work in a clinical laboratory. Bull JFCC 5: 89-95, 1989.
5. Castelli L, Zlotnik H, Ponti R, Vidotto V. First reported Nocardia otitidiscaviarum infection in an AIDS patient in Italy. Mycopathologia 126: 131-136, 1994.
6. Salh B, Fegan C, Hussain A, Jaulim A, Whale K, Webb A. Pulmonary infection with Nocardia caviae in a patient with diabetes mellitus and liver cirrhosis. Thorax 43: 933-934, 1988.
7. Clark NM, Braum DK, Pasternak A, Chenoweth CE. Primary cutaneous Nocardia otitidiscaviarum infection: case report and review. Clin Infect Dis 20: 1266-1270, 1995.
8. Mereghetti L, van der Mee-Marquet N, Dubost AF, Boiron P. Nocardia otitidiscaviarum infection of a traumatic skin wound. Eur J Clin Microbiol Infect Dis 16: 383-384, 1997.
9. Hachisuka Hm Ichiki M, Yoshida N, Nakano S, Sasaki Y. Primary subcutaneous abscess caused by Nocardia otitidiscaviarum. J Am Acad Dematol 21: 137-139, 1989.
10. Wallace RJ Jr, Septimus FJ, Williams TW Jr, et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 4: 315-325, 1982.
11. Berkey P, Moore D, Rolston K. In vitro susceptibilities of Nocardia species to newer antimicrobial agents. Antimicrob Agents Chemother 32: 1078-1079, 1988.
12. Lo W, Rolston KV. Use of imipenem in the treatment of pulmonary nocardiosis. Chest 103: 951-952, 1993.
13. Wallence RJ Jr, Steele LC. Susceptibility testing of Nocardia species for the clinical laboratory. Diagn Microbiol Infect Dis 9: 155-166, 1988.
14. Lerner PI. Nocardia species, in: Principles and Practice of Infectious Disease. Mandell GL, Douglas RG Jr, Bennett JE, Eds. 3rd ed, New York, Churchill Livingstone, 1990, p. 1926-1932.